Premium
A miniature mimic of host defense peptides with systemic antibacterial efficacy
Author(s) -
Sarig Hadar,
Livne Liran,
HeldKuznetsov Victoria,
Zaknoon Fadia,
Ivankin Andrey,
Gidalevitz David,
Mor Amram
Publication year - 2010
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.09-149427
Subject(s) - chemistry , surface plasmon resonance , mechanism of action , microbiology and biotechnology , biophysics , biology , nanotechnology , biochemistry , in vitro , nanoparticle , materials science
Oligomers of acylated lysines (OAKs) are synthetic mimics of host defense peptides (HDPs) with promising antimicrobial properties. Here we challenged the OAK concept for its ability to generate both systemically efficient and economically viable lead compounds for fighting multidrug‐resistant bacteria. We describe the design and characterization of a miniature OAK composed of only 3 lysyls and 2 acyls (designated C 12(ω7) K‐β 12 ) that preferentially targets gram‐positive species by a bacteriostatic mode of action. To gain insight into the mechanism of action, we examined the interaction of OAK with various potential targets, including phospholipid bilayers, using surface plasmon resonance, and Langmuir monolayers, using insertion assays, epifluorescence microscopy, and grazing incidence X‐ray diffraction, in a complementary manner. Collectively, the data support the notion that C 12(ω7) K β 12 damages the plasma‐membrane architecture similarly to HDPs, that is, following a near‐classic 2‐step interaction including high‐affinity electrostatic adhesion and a subsequent shallow insertion that was limited to the phospholipid head group region. Notably, preliminary acute toxicity and efficacy studies performed with mouse models of infection have consolidated the potential of OAK for treating bacterial infections, including systemic treatments of methicillin‐resistant Staphylococcus aureus. Such simple yet robust chemicals might be useful for various antibacterial applications while circumventing potential adverse effects associated with cytolytic compounds.—Sarig, H., Livne, L., Held‐Kuznetsov, V., Zaknoon, F., Ivankin, A., Gidalevitz, D., Mor, A. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24, 1904–1913 (2010). www.fasebj.org